Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) EBT: 2023-2025

Historic EBT for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to -$13.2 million.

  • Camp4 Therapeutics' EBT rose 1.90% to -$13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.6 million, marking a year-over-year decrease of 0.41%. This contributed to the annual value of -$51.8 million for FY2024, which is 5.07% down from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' EBT is -$13.2 million, which was down 5.19% from -$12.6 million recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' EBT peaked at -$11.7 million during Q3 2023, and registered a low of -$13.5 million during Q3 2024.
  • Moreover, its 3-year median value for EBT was -$12.6 million (2025), whereas its average is -$12.7 million.
  • As far as peak fluctuations go, Camp4 Therapeutics' EBT dropped by 15.29% in 2024, and later increased by 1.90% in 2025.
  • Camp4 Therapeutics' EBT (Quarterly) stood at -$13.0 million in 2023, then decreased by 2.22% to -$13.3 million in 2024, then climbed by 1.90% to -$13.2 million in 2025.
  • Its EBT was -$13.2 million in Q3 2025, compared to -$12.6 million in Q2 2025 and -$12.5 million in Q1 2025.